Translations:

Current press release is available also as a translated version. Please, select your language from the menu above.

Press release - 25 October 2004

CapMan to invest in Swedish Gammadata

The funds managed/advised by CapMan are in the process of investing in Swedish Gammadata Mätteknik i Uppsala AB (Gammadata), which develops and provides measurement instruments and analyzers based on fundamental nuclear and material physics. The investment will be used mainly to finance Gammadata’s R&D projects and marketing and sales efforts. As a result of the investment, the CapMan funds will own approx. 31% of the shares in the company. The investment is subject to approval of the majority of the shareholders, and the deal is expected to be closed by the end of November.

Gammadata is one of the leading European companies in the research, development and application of applied nuclear, atomic and surface physics, and it creates instrumentation and solutions for radiation analysis and high-resolution spectroscopy. The market for advanced measurement instruments and analysers developed by Gammadata grows steadily. Gammadata’s customer base includes numerous top research institutes and industrial corporations worldwide.

The company’s business is divided into three units, which are Scienta, Instrument and Services. Scienta designs and develops electron analyzers, ESCA-systems, Instrument designs and OEMs instruments and systems for measurements of ionisation radiation and optical spectroscopy and Services provides measurement systems and services for nuclear radiation protection.

“Gammadata is an exciting and well positioned company. Gammadata’s products have very high performance rates and are of a very high quality. The personnel and management of the company are very competent. We believe that Gammadata will continue its successful and international growth,” says Lars Hagdahl, Senior Partner at CapMan.

“Our ambition is to be one of the world leading suppliers of surface analysis systems, with focus on ESCA. Our industrial customers are mainly to be found in the field of nano technology. We will strengthen our already strong position in surface analysis. The collaboration with and financial support from CapMan is a main key for us to achieve our goals” says Leif Glantz, CEO of Gammadata.


For additional information, please contact:
Mr. Lars Hagdahl, Senior Partner, CapMan Technology Business Unit, Tel. +46 8 585 854 70
Mr. Leif Glantz, CEO Gammadata Mätteknik i Uppsala AB, Tel. +46 18 480 58 00


CapMan Group
CapMan is one of the leading private equity investors in the Nordic countries and specialises in mid-sized buyouts in various industry sectors, technology investments in the IT and telecommunications sectors and investments in life science companies. The CapMan team comprises around 80 people in Helsinki, Stockholm, Copenhagen and Oslo. CapMan manages/advises funds with approx. EUR 1.8 billion in total capital, of which approx. EUR 573 million is managed by the affiliated company Access Capital Partners, which invests in European private equity funds. To date, the funds managed by CapMan have invested in 144 companies in the Nordic countries and exited from 67companies. The latest investments are made in Finnish Tokmanni Oy, Swedish InDex Pharmaceuticals AB, Norwegian Locus AS and Danish Anhydro Group. CapMan Plc is listed on the Main List of the Helsinki Stock Exchange. www.capman.com


Gammadata Mätteknik i Uppsala
Founded in 1986, the Gammadata Group is now a leader in the research, development and application of applied nuclear, atomic and surface physics. With a large number of researchers and staff members, close ties to the academic community and operations throughout the world, the Gammadata Group is creating instrumentation and solutions for radiation analysis and high-resolution spectroscopy. Gammadata is based in Uppsala, north of Stockholm, and it has subsidiaries in Finland and Japan and sales offices in Norway and the UK. The company has 55 employees, of which 13 PhDs. www.gammadata.se